恆逸石化(000703.SZ):第四期員工持股計劃及控股股東員工增持計劃合計購入9428.5704萬股
格隆匯9月1日丨恆逸石化(000703.SZ)公佈,截止2021年9月1日,公司第四期員工持股計劃:杭州博海匯金資產管理有限公司-博海匯金匯鑫8號證券私募投資基金已通過二級市場買入方式購入公司股票累計4993.69萬股,佔公司總股本的1.36%,成交金額約人民幣5.96億元。
截至2021年9月1日,控股股東及附屬企業之部分員工增持計劃:西藏信託有限公司-西藏信託-泓景29號集合資金信託計劃已通過二級市場買入方式購入公司股票累計4434.8804萬股,佔公司總股本的1.21%,成交金額約人民幣5.64億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.